Thursday, 13 June 2013

AstraZeneca buys Pearl Therapeutics in $1.15bn deal



AstraZeneca buys Pearl Therapeutics in $1.15bn deal


The UK's second largest drug company, AstraZeneca, has announced that it will buy US based lung disease drug specialist, Pearl Therapeutics, in a deal worth up to $1.15bn (£742m).

 http://www.pharmaceutical-technology.com/news/newsastrazeneca-buys-pearl-therapeutics-in-115bn-deal?WT.mc_id=DN_News














 animated yellow butterfly

No comments:

Post a Comment